Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014

Young, Ambera; Khanna, Dinesha,b

Current Opinion in Rheumatology: May 2015 - Volume 27 - Issue 3 - p 241–248
doi: 10.1097/BOR.0000000000000172
CLINICAL THERAPEUTICS: Edited by W. Joseph McCune
Buy

Purpose of review To review pharmacologic and nonpharmacologic therapies in the treatment of systemic sclerosis (SSc) from 2011 to 2014 through a systematic review.

Recent findings Our systematic review identifies randomized controlled trials, meta-analyses, systematic reviews, case series, and observational studies which support organ-based therapy with known immunosuppressive agents, novel agents, and hematopoietic stem cell transplantation, and also includes nonpharmacologic therapies improving visceral and physical function.

Summary SSc is an orphan autoimmune disorder with significant morbidity and mortality. Although there has been significant progress over the years in therapeutic options for SSc, the mainstays of treatment are organ-based and primarily symptom management. Our systematic review of the last 4 years of treatment emphasizes known treatment strategies already in practice, but also identifies new therapeutic approaches with additional biologic agents and hematopoietic stem cell transplantation.

aDivision of Rheumatology/Department of Internal Medicine, University of Michigan

bDivision of Rheumatology/Department of Internal Medicine, University of Michigan Scleroderma Program, Ann Arbor, Michigan, USA

Correspondence to Dinesh Khanna, MD, MSc, Division of Rheumatology/Department of Internal Medicine, University of Michigan Scleroderma Program, Suite 7C27, 300 North Ingalls Street, SPC 5422, Ann Arbor, MI 48109, USA. Tel: +1 734 647 8173; fax: +1 734 763 5761; e-mail: khannad@med.umich.edu

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.